Verteporfin for the Treatment of Recurrent High Grade EGFR-Mutated Glioblastoma

Clinical trial NCT04590664 · RECRUITING

Trial details

NCT number: NCT04590664
Sponsor: Emory University
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Glioblastoma Recurrent Glioblastoma

Start date: 2021-01-15
Primary completion: 2025-08-15
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.